These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 27298500)

  • 1. Weekly injection of histaglobulin produces long-term remission in chronic urticaria: A prospective clinical study.
    Rajesh G; Keerthi S; Karthikeyan K; Venkatesan M
    Indian J Pharmacol; 2016; 48(3):292-7. PubMed ID: 27298500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of the Efficacy of Antihistamines in Chronic Spontaneous Urticaria Based on Initial Suppression of the Histamine- Induced Wheal.
    Sánchez J; Zakzuk J; Cardona R
    J Investig Allergol Clin Immunol; 2016; 26(3):177-84. PubMed ID: 27326985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes of some values of allergic reactivity in patients with chronic recurrent urticaria under the effect of histaglobulin treatment].
    Skripkin IuK; Somov BA; Kolesnikova LI; Korableva ZI; Vasilenko TI
    Vestn Dermatol Venerol; 1972 Jan; 46(1):17-21. PubMed ID: 4110996
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative Evaluation of the Therapeutic Efficacy and Safety of Injected Histaglobulin versus Autologous Serum Therapy in Chronic Urticaria.
    Kumar S; Dhillon SS; Brar BK; Singh A
    J Clin Aesthet Dermatol; 2021 Mar; 14(3):38-41. PubMed ID: 33841615
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term efficacy of omalizumab in seven patients with treatment-resistant chronic spontaneous urticaria.
    Silva PM; Costa AC; Mendes A; Barbosa MP
    Allergol Immunopathol (Madr); 2015; 43(2):168-73. PubMed ID: 24731771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of chronic autoimmune urticaria with omalizumab.
    Kaplan AP; Joseph K; Maykut RJ; Geba GP; Zeldin RK
    J Allergy Clin Immunol; 2008 Sep; 122(3):569-73. PubMed ID: 18774392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of leukotriene receptor antagonist with an anti-H1 receptor antagonist for treatment of chronic idiopathic urticaria.
    Wan KS
    J Dermatolog Treat; 2009; 20(4):194-7. PubMed ID: 19085267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic effectiveness of histaglobin preparations in patients with allergic rhinitis and chronic urticaria].
    Gushchin IS; Luss LV; Il'ina NI; Larina ON; Pakhomova LA
    Ter Arkh; 1999; 71(3):57-62. PubMed ID: 10234769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible benefit from treatment of Helicobacter pylori in antihistamine-resistant chronic urticaria.
    Magen E; Mishal J
    Clin Exp Dermatol; 2013 Jan; 38(1):7-12. PubMed ID: 23083221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-life experiences with omalizumab for the treatment of chronic urticaria.
    Sussman G; Hébert J; Barron C; Bian J; Caron-Guay RM; Laflamme S; Stern S
    Ann Allergy Asthma Immunol; 2014 Feb; 112(2):170-4. PubMed ID: 24468258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of a short course of oral prednisone in antihistamine-resistant chronic urticaria: a retrospective analysis.
    Asero R; Tedeschi A
    J Investig Allergol Clin Immunol; 2010; 20(5):386-90. PubMed ID: 20945604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria.
    Staevska M; Popov TA; Kralimarkova T; Lazarova C; Kraeva S; Popova D; Church DS; Dimitrov V; Church MK
    J Allergy Clin Immunol; 2010 Mar; 125(3):676-82. PubMed ID: 20226302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: a retrospective clinical analysis.
    Metz M; Ohanyan T; Church MK; Maurer M
    J Dermatol Sci; 2014 Jan; 73(1):57-62. PubMed ID: 24060603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria.
    Saini S; Rosen KE; Hsieh HJ; Wong DA; Conner E; Kaplan A; Spector S; Maurer M
    J Allergy Clin Immunol; 2011 Sep; 128(3):567-73.e1. PubMed ID: 21762974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized placebo-controlled double-blind pilot study of methotrexate in the treatment of H1 antihistamine-resistant chronic spontaneous urticaria.
    Sharma VK; Singh S; Ramam M; Kumawat M; Kumar R
    Indian J Dermatol Venereol Leprol; 2014; 80(2):122-8. PubMed ID: 24685847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children.
    Singh-Franco D; Ghin HL; Robles GI; Borja-Hart N; Perez A
    Clin Ther; 2009 Aug; 31(8):1664-87. PubMed ID: 19808127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to assess disease activity in patients with chronic urticaria?
    Młynek A; Zalewska-Janowska A; Martus P; Staubach P; Zuberbier T; Maurer M
    Allergy; 2008 Jun; 63(6):777-80. PubMed ID: 18445192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective randomized non-blinded clinical trial on the use of dapsone plus antihistamine vs. antihistamine in patients with chronic idiopathic urticaria.
    Engin B; Ozdemir M
    J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):481-6. PubMed ID: 18081753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levocetirizine and rupatadine in chronic idiopathic urticaria.
    Johnson M; Kwatra G; Badyal DK; Thomas EA
    Int J Dermatol; 2015 Oct; 54(10):1199-204. PubMed ID: 25521304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihistamines in urticaria and angioedema.
    Black AK; Greaves MW
    Clin Allergy Immunol; 2002; 17():249-86. PubMed ID: 12113219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.